(Q36265085)

13 August 2017

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali (English)

1 reference

13 August 2017

0 references

0 references

0 references

1 reference

1 reference

11

Matthias Niedrig

1 reference

13 August 2017

5

Abraham Hodgson

1 reference

13 August 2017

6

Samba O Sow

1 reference

13 August 2017

8

Brian D Plikaytis

1 reference

13 August 2017

7

Godwin C Enwere

1 reference

13 August 2017

Panchali Roy Chowdhury

1

1 reference

13 August 2017

Christian Meier

2

1 reference

13 August 2017

Hewad Laraway

3

1 reference

13 August 2017

Yuxiao Tang

4

1 reference

13 August 2017

Prasad S Kulkarni

9

1 reference

13 August 2017

Marie-Pierre Preziosi

10

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2015

1 reference

Clinical Infectious Diseases

13 August 2017

1 reference

13 August 2017

61 Suppl 5

1 reference

13 August 2017

S586-93

1 reference

Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

The phylogeny of yellow fever virus 17D vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Yellow Fever: 100 Years of Discovery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Yellow fever: the recurring plague

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

30 September 2017

Yellow fever: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Comparative analysis of two rates

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4639505

Yellow fever vaccine: past, present and future

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIV603

17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26553692

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Vaccines and vaccination against yellow fever. WHO position paper -- June 2013

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26553692

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Meningococcal A conjugate vaccine: updated guidance, February 2015

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26553692

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CID/CIV603

1 reference

13 August 2017

1 reference

13 August 2017

1 reference